2-Chloro-4-Methylpyrimidine (CAS 13036-57-2): Your Key Pharmaceutical Intermediate Supplier

Discover high-purity 2-Chloro-4-Methylpyrimidine, a critical pharmaceutical intermediate. We are a leading manufacturer and supplier in China, offering custom synthesis services for your advanced drug development needs.

Get a Quote & Sample

Advantages of Partnering with Our Company

Exceptional Purity and Quality

We guarantee a purity of >98% for our 2-Chloro-4-Methylpyrimidine, crucial for achieving high yields and quality in your synthesis of pharmaceutical intermediates. As a dedicated manufacturer, quality control is paramount.

Competitive Pricing from a China Supplier

Benefit from cost-effective sourcing for your pharmaceutical intermediates. Our strategic location as a supplier in China allows us to offer competitive prices for 2-Chloro-4-Methylpyrimidine without compromising on quality.

Expertise in Custom Synthesis

Leverage our custom synthesis capabilities to develop specialized compounds. We cater to unique project needs, ensuring you get the exact pharmaceutical intermediates required for your research and production.

Key Applications of 2-Chloro-4-Methylpyrimidine

Pharmaceutical Synthesis

As a vital building block, 2-Chloro-4-Methylpyrimidine (CAS 13036-57-2) is extensively used in the synthesis of Active Pharmaceutical Ingredients (APIs), most notably as an intermediate for Dabrafenib Mesylate.

Drug Discovery and Development

Researchers rely on high-quality intermediates like 2-Chloro-4-Methylpyrimidine to explore new therapeutic compounds and optimize existing drug formulations. Purchase this essential chemical for your R&D projects.

Chemical Research

Beyond pharmaceuticals, this pyrimidine derivative is valuable in broader chemical research, serving as a versatile reagent in organic synthesis and material science applications.

Custom Chemical Projects

Our custom synthesis services ensure that you can obtain precisely tailored versions of 2-Chloro-4-Methylpyrimidine for specialized applications or novel research pathways.